👉 The 2025 Crypto Outlook

Here's which targets BTC, ETH, DOGE could hit in 2025.

You're receiving this email because you're subscribed to Future Finance from Benzinga. To manage your subscription, click the link at the bottom of this email.


Gm and Happy Monday!

Bitcoin, Ethereum, Dogecoin are all going to have a great 2025, according to Galaxy Research — here are its price predictions.

MicroStrategy has bought another $209 million worth of Bitcoin, bringing its buying streak to eight straight weeks.

Plus, investors who would like to learn more about SBC Medical’s aggressive growth strategy can explore the latest announcements here.

TOP STORY

New all-time highs for BTC, ETH, DOGE are coming in 2025.

But Galaxy Research did not only predict which numbers we’re going to hit but also a ton of other developments in the crypto sector.

What’s going to happen with AI, stablecoins, and crypto regulation?

SBC Medical (NASDAQ: SBC) is closing out 2024 with a laser focus on growth, revealing a growth strategy with a focus on the Asian and U.S. markets, including through both M&A and an organic expansion. In recent weeks, SBC Medical announced the acquisition of Singapore’s  Aesthetic Healthcare Holdings (AHH), a multi-unit owner of aesthetic treatment clinics in Singapore. The all-cash transaction is reflective of SBC Medical’s acquisitiveness and confidence as it capitalizes on a resilient consumer. On the organic growth side, SBC Medical has launched a B2B wellness offering for its corporate clients designed to promote employee wellness, leading to greater recruitment and loyalty. Investors who would like to learn more about SBC Medical’s aggressive growth strategy can explore the latest announcements here.

QUICK N DIRTY

A strategic Bitcoin reserve in 2025? Not a good idea, according to an analyst that told Benzinga the public “won’t tolerate that.”

Germany, or to be precise its former finance minister, doesn’t agree with this assessment — Christian Lindner thinks the European Central Bank should buy Bitcoin.

Ethereum could, unbothered by the reserve talk, quietly outperform Bitcoin in the next quarter — a prominent whale trader cites 3 reasons to be bullish on ETH.

FINTECH FOCUS

Michael Saylor has done it again.

Another $209 million have been converted into bitcoin.

MicroStrategy’s weekly buying streak stands at eight consecutive weeks now.

But there is one curious trend that is worth noting and that might be quite bearish…

What’s with MicroStrategy’s buying size over the past few weeks?

BEFORE YOU GO

Were you forwarded this email? Click here to subscribe.

And be sure to check out our other newsletters:

Ring The Bell: Created for market enthusiasts by market enthusiasts, this twice-daily newsletter delivers top stories, fast movers, and hot trade ideas straight to your inbox. Subscribe here.

Cannabis Daily: A must-read daily briefing for cannabis investors, operators, and enthusiasts. Join our list of industry veterans to jump start your morning. Subscribe here.

Real Estate Weekly: Where we highlight the movers and the losers, the upgrades and the downgrades, the top stories and opportunities in the trillion dollar REIT and real asset industry. Subscribe here.

Advisor: Tailor-made for Financial Advisors, this weekly newsletter has industry-specific insights, analysis, and news. Subscribe here.

Tech Trends: Get the inside scoop on AI, the hottest gadgets, and mind-blowing tech trends. Subscribe here.

Disclaimer: This communication from Benzinga is for informational purposes only. It is not intended to serve as a recommendation to buy, sell, or hold any security and is not an offer or sale of a security. Information contained within should not be perceived as a research report and is not intended to serve as the basis for any investment decision. Any third-party views reflected herein do not reflect the opinion of Benzinga. All investments involve risk and the past performance of a security does not guarantee future results or returns. There is always the potential for financial loss when investing in securities or other financial products. Investors should consider their investment objectives and risks before investing. Benzinga is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad. Please see 17b disclosure linked in the campaign page for more information.